Navigation Links
Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
Date:5/20/2008

lf of this year.

"There are still significant unmet needs in the treatment of COPD. These efficacy and safety data from the Phase II trials are very encouraging," said Lawrence S. Olanoff, M.D., Ph.D., President and Chief Operating Officer of Forest Laboratories. "We look forward to the completion of ACCLAIM I & II trials and continuing the clinical development of aclidinium for the treatment of COPD."

Additional Clinical Data

Three additional clinical trials assessing the safety and pharmacokinetics of aclidinium were also presented at this meeting.

A randomized, double-blind, placebo- and active-controlled clinical trial evaluating the cardiovascular safety and pharmacokinetics of aclidinium (200 or 800 mcg) in 272 healthy subjects, showed no effect on QT interval at doses up to 800 mcg. Furthermore, aclidinium was well-tolerated, with most adverse events being of mild intensity, related to electrode attachment, and of similar incidence across treatment groups. Maximum concentration of aclidinium was reached 5 to 30 minutes post-dose and aclidinium was not detectable in the plasma after one hour.

Results of two other randomized, placebo-controlled studies, each in 16 healthy subjects, were presented. In the first, subjects were exposed to single doses of aclidinium (600 -- 6000 mcg) and placebo to determine pharmacokinetics, safety and tolerability, and maximum tolerated dose. For all doses, aclidinium was undetectable in plasma beyond 3 hours post-dose. Aclidinium was well tolerated across this dosage range, with headache (n=10) and fatigue (n=5) being the most frequently reported adverse events. No serious adverse events were reported. The second study assessed the safety, tolerability, and pharmacokinetics of aclidinium after multiple doses. Subjects received 5 days of treatment with aclidinium 200, 400, 800 mcg or placebo. Aclidinium was undetectable in plasma after all studied doses beyond 1 hour post-dose. Aclidinium was we
'/>"/>

SOURCE Forest Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
2. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
3. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
4. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
5. Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product
6. InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
7. Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer
8. TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
9. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
10. GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab)
11. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... Juli 2015 BioClinica®, Inc ., ... Studien, gab heute bekannt, dass es mit MediciGroup ... Gewinnung und Erhalt von Patienten übernommen hat. ... , Ltd. und Access to Patients, LLC. Medici ... zum Auffinden von Patienten, die für die Nachbeobachtung ...
(Date:7/7/2015)... The Global Breast Pumps Market is ... an estimated CAGR of 7.6% from 2014 to 2020, according ... of innovative technologies including hand free breast pumps, growing women ... advantages of breast milk are expected to drive breast pump ... untapped growth opportunities in emerging markets such as ...
(Date:7/7/2015)...   Bionik Laboratories Corp. (OTCBB: BNKL), ... core focus in robotic exoskeleton technology for users ... today that it has completed an additional sale ... its common stock and warrants for aggregate gross ... placement transaction.  This equity financing is the sixth ...
Breaking Medicine Technology:BioClinica übernimmt MediciGroup 2BioClinica übernimmt MediciGroup 3BioClinica übernimmt MediciGroup 4Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 4Bionik Laboratories Completes US$13.1 Million Private Placement 2Bionik Laboratories Completes US$13.1 Million Private Placement 3
... 2011  Merrimack Pharmaceuticals, Inc. announced today that the ... 1 clinical study combining MM-121, a fully human ... and irinotecan (Camptosar®) in patients with advanced cancers. ... The Phase 1 study evaluates the safety ...
... Addressing concerns over anti-mail-service pharmacy legislation, New York ... the legislature have agreed to amend NY AB 5502-B, ... use of the lower cost mail-service pharmacy option. ... admonition to the Legislature to improve this costly, anti-consumer ...
Cached Medicine Technology:Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121 in Combination with Cetuximab and Irinotecan in Patients with Advanced Cancers 2PCMA: Governor Cuomo's Call to Amend Anti-Mail-Service Pharmacy Law Protects Employers and Consumers 2PCMA: Governor Cuomo's Call to Amend Anti-Mail-Service Pharmacy Law Protects Employers and Consumers 3
(Date:7/7/2015)... , ... July 07, 2015 , ... Silverado today issues ... ground as early as Summer 2015 on a four-acre site in Bellingham, Washington. Cordata ... the support of city officials and other members of the local community. , The ...
(Date:7/7/2015)... and CHICAGO (PRWEB) , ... July 07, 2015 ... ... healthcare business development and growth strategy expert Jay Warden as Senior Vice President, ... for the company’s efforts to provide the best solutions to healthcare providers’ needs ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... cancer screenings at the Aspen Ideas Festival (AIF), identifying 18 possible melanomas and ... diagnoses must be confirmed with additional testing. , The Aspen Ideas Festival, which ...
(Date:7/7/2015)... , ... July 07, 2015 , ... ... MRI services, is debuting their brand new website. The website’s goal is to ... a wider selection of patient tools, including requesting appointments online. , Part of ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... The United ... AIDS Action Committee of Massachusetts , and the Multicultural AIDS Coalition $3.78 ... other men who have sex with men (MSM) and transgender women, the groups ...
Breaking Medicine News(10 mins):Health News:New Silverado Memory Care Community Receives Unanimous Approval from Design Review Board 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 4Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3
... the important risk factor for psychoactive drugs abuse//. ... like marijuana, stimulants, opiates, cocaine and psychedelics was ... genetic makeup – researchers report. ,In ... Virginia Commonwealth University researchers, in collaboration with researchers ...
... All India Institute of Medical Sciences remained crippled today ... protest the move to sack its Director P Venugopal//. ... closed since last evening as resident doctors and faculty ... body headed by Union Health Minister A Ramadoss recommended ...
... A succinct report has laid unbelievable blunders on the table ... slip-ups or have just escaped by the skin of their ... falsifying figures.NHS is simply unable to fathom the losses for ... could be close to a million ,The slip ...
... to a recent research it was found that teenagers who ... other hard drugs// later in their life. ,Teenagers ... to the positive emotion that they derive by taking these ... which further leads a person to get exposed to other ...
... issue", consuming 30c for every $1 spent on health, according ... in its report on this year's estimates for Vote Health,called ... and indicated exhausted doctors and nurses as one factor. ... who suffered an unintended or negative event while in care. ...
... discovered a safe and effective way to sanitize seeds used ... colleagues at the University of Guelph, have developed a sanitizer ... the same chemicals used in toothpaste and contact lens solutions. ... by a magic bullet is that it can selectively kill ...
Cached Medicine News:Health News:Genetic Factors linked with Drug Dependence and Abuse 2Health News:Sanitizer For Contaminated Sprouts Developed 2
Liquichek™ Ethanol/Ammonia Control is a liquid product used to monitor ethanol and ammonia test procedures in the clinical laboratory....
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Lyphochek Assayed Chemistry Control requires no special diluent and has good reconstituted stability for enzymes and CO2. It is assayed for most major instruments and methodologies....
Lyphochek Benzo/TCA Control Set A is ideal for monitoring HPLC methods for identification and quantitation of benzodiazepines and tricyclic antidepressant drugs....
Medicine Products: